These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
220 related items for PubMed ID: 36859300
1. Denosumab-induced hypocalcemia post bariatric surgery-a severe and protracted course: a case report. Awang MH, Hatta SFWM, Mohamad AF, Ghani RA. J Med Case Rep; 2023 Mar 02; 17(1):73. PubMed ID: 36859300 [Abstract] [Full Text] [Related]
3. Severe and prolonged hypocalcemia after a single dose of denosumab for metastatic breast cancer with diffuse bone involvement without prior calcium/vitamin D supplementations. Uhm SJ, Hall JA, Herrington JD. J Oncol Pharm Pract; 2021 Jul 02; 27(5):1287-1290. PubMed ID: 33081580 [Abstract] [Full Text] [Related]
7. Reducing the risk of denosumab-induced hypocalcemia in patients with advanced chronic kidney disease: a quality improvement initiative. Kanagalingam T, Khan T, Sultan N, Cowan A, Thain J, Hoy C, Ledger S, Clemens KK. Arch Osteoporos; 2023 Nov 21; 18(1):138. PubMed ID: 37985504 [Abstract] [Full Text] [Related]
8. Risk Analysis of Denosumab-Induced Hypocalcemia in Bone Metastasis Treatment: Renal Dysfunction Is Not a Risk Factor for Its Incidence in a Strict Denosumab Administration Management System with Calcium/Vitamin D Supplementation. Saito Y, Takekuma Y, Komatsu Y, Sugawara M. Biol Pharm Bull; 2021 Nov 21; 44(12):1819-1823. PubMed ID: 34853264 [Abstract] [Full Text] [Related]
9. SEVERE, PROLONGED, DENOSUMAB-INDUCED HYPOCALCEMIA WITH RECOVERY AFTER 111 DAYS OF HIGH-DOSE CALCIUM SUPPLEMENTATION. McCaleb RV, Johnson JT. AACE Clin Case Rep; 2019 Nov 21; 5(1):e82-e85. PubMed ID: 31967007 [Abstract] [Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P. Cochrane Database Syst Rev; 2022 Feb 01; 2(2022):. PubMed ID: 36321557 [Abstract] [Full Text] [Related]
13. [Symptomatic hypocalcaemia on denosumab use]. Baptista Lopes V, Robbrecht D, van Thiel S, van Guldener C. Ned Tijdschr Geneeskd; 2013 Feb 01; 157(29):A6159. PubMed ID: 23859106 [Abstract] [Full Text] [Related]
15. Post-craniopharyngioma surgery hypocalcemia due to denosumab use for osteoporosis: A case report. Jia L, Hu Y, Jin G. Medicine (Baltimore); 2024 Sep 13; 103(37):e39649. PubMed ID: 39287282 [Abstract] [Full Text] [Related]
19. Severe hypocalcemia following denosumab treatment in a patient with secondary osteoporosis associated with primary sclerosing cholangitis. Yasuda Y, Iwama S, Arima H. Endocr J; 2019 Mar 28; 66(3):271-275. PubMed ID: 30713246 [Abstract] [Full Text] [Related]
20. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)]. Lorenzo Sellares V, Torregrosa V. Nefrologia; 2008 Mar 28; 28 Suppl 3():67-78. PubMed ID: 19018742 [Abstract] [Full Text] [Related] Page: [Next] [New Search]